2017 prize winners

ACP McElwain Prize
AstraZeneca Young Investigator Prize
British Association of Cancer Research (BACR) Hamilton Fairley Poster Prize
British Association of Cancer Research (BACR) AstraZeneca Young Scientist Frank Rose Award
British Association of Cancer Research (BACR) Roger Griffin Prize for Cancer Drug Discovery
Cancer Research UK Future Leaders Prize
Cancer Research UK Lifetime Achievement in Cancer Research Prize
Cancer Research UK Jane Wardle Prevention & Early Diagnosis Prize
Cancer Research UK Translational Cancer Research Prize
Children’s Cancer and Leukaemia Group (CCLG) McElwain Award
The Company of Biologists Travel Awards
National Cancer Research Institute (NCRI) Prize Awards
National Cancer Research Institute (NCRI) Werth Trust Award
Royal College of Radiologists Ross Prizes

 

 

ACP McElwain Prize

TRACERx – TRAcking non-small cell lung Cancer Evolution through therapy (Rx)

Mariam Jamal-Hanjani, UCL Cancer Institute, UK

 

AstraZeneca Young Investigator Poster Prize

ER reactivation following long-term estrogen deprivation drives cell death mediated by an unfolded protein response

Sarah Hosford, Dartmouth College, USA

 

British Association of Cancer Research (BACR) Hamilton Fairley Poster Prize

ELTD1 is a highly conserved, non-canonically signalling adhesion GPCR regulating NOTCH, KIT and endothelial sprouting

David Favara, University of Oxford, UK

 

British Association of Cancer Research (BACR) AstraZeneca Young Scientist Frank Rose Award

Focal Adhesion Kinase – a new target in cancer immunotherapy

Alan Serrels, The University of Edinburgh, UK

 

British Association of Cancer Research (BACR) Roger Griffin Prize for Cancer Drug Discovery

Discovery of potent, selective and orally bioavailable CDK8/CDK19 kinase modulators

Aurélie Mallinger, Institute of Cancer Research, UK

 

Cancer Research UK Future Leaders Prize

Gerhardt Attard, Institute of Cancer Research, UK
Simon Leedham, University of Oxford, UK
Santiago Zelenay, CRUK Manchester Institute, UK

 

Cancer Research UK Jane Wardle Prevention & Early Diagnosis Prize

Greg Rubin, Newcastle University, UK

 

Cancer Research UK Lifetime Achievement in Cancer Research Prize

Jack Cuzick, Queen Mary University of London, UK

 

 

Cancer Research UK Translational Cancer Research Prize

The Tumour Heterogeneity Team led by Charles Swanton, Francis Crick Institute, UK

 

 

Children’s Cancer and Leukaemia Group (CCLG) Award

Simulated low dose cone beam CT (CBCT) in paediatric patients

Abigail Bruce Atkinson, University of Manchester, UK

 

The Company of Biologists Travel Awards

Breast symptoms and the risk of subsequent interval cancers and lethal breast cancers

Deependra Singh, University of Tampere, Finland


The developmental transcription factor ELF3 is critical for lung tumourigenesis

Katey Enfield, British Columbia Cancer Research Centre, Canada


AMPK activation via metformin enhances survival of clinically dormant residual ER+ breast tumor cells during estrogen deprivation therapy

Riley A. Hampsch, Dartmouth College, USA


Sphingosine-1-phosphate receptor type 1 (S1P1) loss mediated T-cell sequestration in bone marrow amidst glioblastoma (GBM): a novel mode of cancer-induced immunosuppression

Pakawat Chongsathidkiet, Duke University, USA

 

National Cancer Research Institute (NCRI) Prize Awards

The impact of cognitive impairment on treatment allocation of elderly women with early breast cancer

Charlene Martin, The University of Sheffield, UK


Metastatic Colorectal Cancer (mCRC) Patient Derived Organoids (PDOs) as a preclinical tool to understand mechanisms of resistance to anti-angiogenic drugs

Somaieh Hedayat, Institute of Cancer Research, UK


HDAC inhibitors overcome resistance to IAP inhibitors in colorectal cancer by downregulating FLIP

Katie Stott, CCRCB Queens University Belfast, UK


Leukaemia inhibitory factor: a novel mediator of prostate cancer-induced bone disease?

Christina Turner, University of Oxford, UK


Clinical and dosimetric factors impacting radiation pneumonitis in isotoxically dose-escalated NSCLC

Sindu Vivekanandan, University of Oxford, UK

 

Investigation of anti-cancer activity of disulfiram in primary pancreatic ductal adenocarcinoma (PDAC) cells

Ogechi Nkeonye, University of Wolverhampton, UK

 

National Cancer Research Institute (NCRI) Werth Trust Award

Kevin Shee, Geisel School of Medicine at Dartmouth, USA

 

Royal College of Radiologists (RCR) Ross Prizes

Immunohistochemical assessment of cellular proliferation marker Ki67 in relation to prostate radiotherapy fractionation and prognosis in Trans-CHHiP

Anna Wilkins, The Institute of Cancer Research, UK


Development and validation of a 28-gene hypoxia signature for localised prostate cancer

Lingjian Yang, University of Manchester, UK